Du GB - Search Results

1

Metachronous double primary malignant tumors with nasopharyngeal carcinoma and diffuse malignant peritoneal mesothelioma accompanied with paraneoplastic syndromes treated with nivolumab: A case report.

Tang LK, Li ZK, Xiang YL, Ma DY, Du GB. Tang LK, et al. Among authors: du gb. Medicine (Baltimore). 2023 Jul 28;102(30):e34349. doi: 10.1097/MD.0000000000034349. Medicine (Baltimore). 2023. PMID: 37505161 Free PMC article.

2

Diagnostic value of microRNA-148/152 family in non-small-cell lung cancer (NSCLC): A systematic review and meta-analysis.

Cheng L, Li Q, Tan B, Ma D, Du G. Cheng L, et al. Medicine (Baltimore). 2021 Dec 3;100(48):e28061. doi: 10.1097/MD.0000000000028061. Medicine (Baltimore). 2021. PMID: 35049226 Free PMC article.

3

Synchronous triple primary malignant tumours in the bladder, prostate, and lung harbouring TP53 and MEK1 mutations accompanied with severe cardiovascular diseases: A case report.

Li ZK, Zhao Q, Li NF, Wen J, Tan BX, Ma DY, Du GB. Li ZK, et al. Among authors: du gb. Open Med (Wars). 2022 Dec 14;17(1):2046-2051. doi: 10.1515/med-2022-0616. eCollection 2022. Open Med (Wars). 2022. PMID: 36568519 Free PMC article.

4

Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report.

Zhao Q, Li ZK, Gui Y, Ma DY, Du GB, Li XF. Zhao Q, et al. Among authors: du gb. Open Life Sci. 2023 Feb 9;18(1):20220555. doi: 10.1515/biol-2022-0555. eCollection 2023. Open Life Sci. 2023. PMID: 36820209 Free PMC article.

5

miR-186 regulates epithelial-mesenchymal transformation to promote nasopharyngeal carcinoma metastasis by targeting ZEB1.

Tang L, Xiang Y, Zhou J, Li T, Jia T, Du G. Tang L, et al. Braz J Otorhinolaryngol. 2024 Jan-Feb;90(1):101358. doi: 10.1016/j.bjorl.2023.101358. Epub 2023 Nov 6. Braz J Otorhinolaryngol. 2024. PMID: 37989078 Free PMC article.

6

Study of PEG-rhG-CSF for the prevention of neutropenia in concurrent chemoradiotherapy for nasopharyngeal carcinoma.

Yang L, Yu L, Du X, Cui Y, Du G. Yang L, et al. PLoS One. 2025 Jan 15;20(1):e0315001. doi: 10.1371/journal.pone.0315001. eCollection 2025. PLoS One. 2025. PMID: 39813291 Free PMC article. Clinical Trial.

7

A Real-World Study on Diagnosis and Treatment of Uterine Sarcoma in Western China.

Li D, Yin N, Du G, Wang S, Xiao Z, Chen J, Chen W. Li D, et al. Int J Biol Sci. 2020 Jan 1;16(3):388-395. doi: 10.7150/ijbs.39773. eCollection 2020. Int J Biol Sci. 2020. PMID: 32015676 Free PMC article.

8

CD155-Prognostic and Immunotherapeutic Implications Based on Multiple Analyses of Databases Across 33 Human Cancers.

Zhang H, Yang Z, Du G, Cao L, Tan B. Zhang H, et al. Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033820980088. doi: 10.1177/1533033820980088. Technol Cancer Res Treat. 2021. PMID: 33576304 Free PMC article.

9

Safety and efficacy of pulsed low-dose rate radiotherapy for local recurrent esophageal squamous cell carcinoma after radiotherapy: Study protocol for a prospective multi-center phase II trial.

Li J, Zhao Z, Du G, Dai T, Zhen X, Cai H, Liao D, Xiang M, Wen Y, Geng L, Yang X, Feng G, Zhang Y, Bai J, Liu L, Du X. Li J, et al. Medicine (Baltimore). 2019 Jun;98(26):e16176. doi: 10.1097/MD.0000000000016176. Medicine (Baltimore). 2019. PMID: 31261551 Free PMC article.

10

Immune checkpoints related-LncRNAs can identify different subtypes of lung cancer and predict immunotherapy and prognosis.

Zhang H, Liu M, Du G, Yu B, Ma X, Gui Y, Cao L, Li X, Tan B. Zhang H, et al. J Cancer Res Clin Oncol. 2022 Jul;148(7):1597-1612. doi: 10.1007/s00432-022-03940-3. Epub 2022 Mar 17. J Cancer Res Clin Oncol. 2022. PMID: 35296921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters